MOHS acquires major pharma company

  • 📰 TheManilaTimes
  • ⏱ Reading Time:
  • 22 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 92%

MOHS Notícia

Acquires,Major,Pharma

IN pursuit of its strategy of vertical integration of its flagship healthcare and wellness business, MOHS Analytics has acquired majority ownership of Remed Pharmaceuticals Inc., a research and development driven company founded in 2002 by pharmaceutical industry pillar Remedios Rivera,who is also the chairman and president.

Remed owns established brands covering products in four different pharmaceutical categories – Vitacare, Respicare, Pediacare and Gastrocare with over 20 brands in its portfolio.These products are distributed through some 4,500 outlets in major national and regional drugstores and pharmacy chains.Remed has grown to a leadership position in some of the pharmaceutical categories it is present in, and it is poised to introduce five more brands in the coming months.

From this platform of and experience with affordable health care products, MOHS has diversified into other areas of health care, including healthcare software and technologies, and point of care innovative systems.'Vertical integration of our health care business allows MOHS to better control costs to make our products more affordable and our business more sustainable,' MOHS Chairman and CEO Michael Hortaleza said.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 2. in PT
 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

MOHS acquires major pharma companyIn pursuit of its strategy of vertical integration of its flagship healthcare and wellness business, MOHS Analytics has acquired majority ownership of
Fonte: MlaStandard - 🏆 20. / 55 Consulte Mais informação »